Chemical Biology Program
The Yueming Li Lab
Research

Research Interests
Basic & Translational research in Cancer and Alzheimer’s disease:
From disease mechanism to therapeutic development.
Research Areas
- Target Identification & Drug Discovery
- Chemical Biology & Medicinal Chemistry
- Biochemistry & Enzymology
- Biophysics & Structural Biology
- Animal models & Behavior
- Neurobiology & Neuroinflammation
- Autophagy, Protein Aggregation & Clearance
Research Projects

Featured News


Publications Highlights
Nie P, Kalidindi T, Nagle VL, et al. Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe. Clin Cancer Res. 2021;27(22):6145-6155. doi:10.1158/1078-0432.CCR-21-0940
Hur, J.-Y., Frost, G. R., Wu, X., Crump, C., Pan, S. J., Wong, E., … Li, Y.-M. (2020). The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease. Nature. doi:10.1038/s41586-020-2681-2
Mekala, S., Nelson, G., & Li, Y.-M. Recent developments of small molecule γ-secretase modulators for Alzheimer’s disease. RSC Medicinal Chemistry, 11(9), 1003-1022. doi:10.1039/D0MD00196A (2020)
People

Yueming Li, PhD
- Dr. Yueming Li studies disease mechanism of Cancer and Alzheimer’s, with the goal of developing novel therapeutics for clinical use.
- PhD, University of California Berkeley
- [email protected]
- Email Address
- 646-888-2194 or 2193
- Office Phone
Members







Lab Head

Administrative Assistant

Senior Research Scientist

Postdoctoral Fellow

Postdoctoral Fellow

Graduate Student

Graduate Student

Graduate Student

Graduate Student

Graduate Student

Graduate student


Senior Research Scientist

Postdoctoral Fellow

Graduate student

Postdoctoral Fellow

Graduate Student


- Weill Medical College of Cornell University, NY, NY

- Weill Medical College of Cornell University, NY, NY

- Weill Medical College of Cornell University, NY, NY

- Weill Medical College of Cornell University, NY, NY

- PhD in Immunology from Heinrich Heine University, Germany (2015)

- Stony Brook University, Stony Brook, New York

- Stanford University, Standford CA
- Molecular Virology, Institute of Virology, Moscow, Russia
Lab Alumni

Graduate Student

Graduate Student

Laboratory Manager

Graduate Student

Postdoctoral Fellow

Graduate Student
Research Fellow

Postdoctoral Fellow

Graduate Student

Postdoctoral Fellow

Graduate Student

Graduate Student

Graduate Student

Graduate Student

Research Technician

Postdoctoral Fellow

Postdoctoral Fellow

Graduate Student
Graduate Student

Visiting Student

Visiting Scholar

Senior Research Scientist

Postdoctoral Fellow
Graduate Student
Graduate Student
Graduate Student

Research Fellow
Graduate Student
Sabbatical Professor

Research Fellow
Research Technician
Research Fellow
Research Fellow
Research Fellow
Research Fellow
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs
Career Opportunities
Get in Touch
-
Lab Head Email
-
Office Phone
-
Office Fax
-
Lab Phone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Yueming Li discloses the following relationships and financial interests:
-
BrightFocus Foundation
Professional Services and Activities -
Cure Alzheimer's Fund
Professional Services and Activities
-
Jiangsu Continental Medical Development Co
Intellectual Property Rights
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].